Mirum Pharmaceuticals (MIRM) Payables: 2020-2025
Historic Payables for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Sep 2025 value amounting to $12.2 million.
- Mirum Pharmaceuticals' Payables rose 27.47% to $12.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.1 million, marking a year-over-year increase of 31.07%. This contributed to the annual value of $14.6 million for FY2024, which is 97.11% up from last year.
- Per Mirum Pharmaceuticals' latest filing, its Payables stood at $12.2 million for Q3 2025, which was down 31.09% from $17.7 million recorded in Q2 2025.
- In the past 5 years, Mirum Pharmaceuticals' Payables ranged from a high of $17.7 million in Q2 2025 and a low of $4.9 million during Q1 2022.
- In the last 3 years, Mirum Pharmaceuticals' Payables had a median value of $11.6 million in 2025 and averaged $11.6 million.
- Per our database at Business Quant, Mirum Pharmaceuticals' Payables spiked by 190.89% in 2021 and then crashed by 31.87% in 2024.
- Quarterly analysis of 5 years shows Mirum Pharmaceuticals' Payables stood at $9.2 million in 2021, then fell by 5.19% to $8.7 million in 2022, then dropped by 14.66% to $7.4 million in 2023, then spiked by 97.11% to $14.6 million in 2024, then rose by 27.47% to $12.2 million in 2025.
- Its Payables was $12.2 million in Q3 2025, compared to $17.7 million in Q2 2025 and $11.6 million in Q1 2025.